Marc A. Kedde - Concepedia

Author

Marc A. Kedde

Also Known As

M.A Kedde, M.A. Kedde, Marc A. Kedde

Publications

215

Citations

H-Index

Concepts

All Affiliations

Marc A. Kedde is an author at Vrije Universiteit Amsterdam specializing in medicine, pharmacology, and pharmacotherapy.

#	Concept	H-Index	Publications	Citations
1	Medicine	5	5	206
2	Biochemistry	2	2	37
3	Natural Sciences	1	1	21
4	Chemical Biology	1	1	21
5	Molecular Biology	1	1	21

Marc A. Kedde

Publications

206

Citations

H-Index

Page 1

	Year	Citations
Dose-Finding and Pharmacokinetic Study of Cisplatin, Gemcitabine, and SU5416 in Patients With Solid Tumors Bart C. Kuenen, Lee S. Rosen, Egbert F. Smit, Journal of Clinical Oncology Solid TumorsMedicineCoagulation CascadePharmacologyPharmacokinetic Study	2002	128
A phase I study of monohydroxyethylrutoside in healthy volunteers Anja M. Willems, A. Bruynzeel, Marc A. Kedde, Cancer Chemotherapy and Pharmacology MedicineHealthy VolunteersPharmacological Study	2005	29
The chemical reactivity of BNP7787 and its metabolite mesna with the cytostatic agent cisplatin: comparison with the nucleophiles thiosulfate, DDTC, glutathione and its disulfide GSSG Miranda Verschraagen, Marc A. Kedde, Frederick H. Hausheer, Cancer Chemotherapy and Pharmacology Disulfide GssgCytostatic Agent CisplatinMedicinal ChemistryBiochemistryNatural Sciences	2003	21
Bioavailability and pharmacokinetics of the cardioprotecting flavonoid 7-monohydroxyethylrutoside in mice Mohamed Hassan, Marc A. Kedde, Ursula T. H. Zwiers, Cancer Chemotherapy and Pharmacology Pharmacological StudyBiochemistryMedicinePhysiologyExperimental Pharmacology	2003	16
The cardioprotector monoHER does not interfere with the pharmacokinetics or the metabolism of the cardiotoxic agent doxorubicin in mice Mohamed Hassan, Marc A. Kedde, Ursula T. H. Zwiers, Cancer Chemotherapy and Pharmacology Heart FailureCardiovascular DiseaseMedicinePhysiologyCardioprotector Monoher	2003	12

Page 1